VEGF and VEGF Receptor-1 Concentration in Vestibular Schwannoma Homogenates Correlates to Tumor Growth Rate
- 1 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 26 (1) , 98-101
- https://doi.org/10.1097/00129492-200501000-00017
Abstract
Vascular endothelial growth factor (VEGF) is one of the most potent mediators of angiogenesis, which is a mandatory process during tumor growth. Immunohistochemical studies have demonstrated VEGF expression in vestibular schwannomas (VS), and a semi-quantitation of staining intensity indicated a correlation between tumor growth rate and VEGF expression. The present objectives were to determine the concentration of VEGF and the high-affinity receptor VEGFR-1 in VS homogenates and to examine a possible correlation with symptom duration, tumor size, or growth rate. Prospective selection of 27 patients with VS growth determined by repeated magnetic resonance imaging. Patient files were reviewed for symptom duration and all magnetic resonance images reviewed for determination of tumor size and growth rate. ELISA was used for determination of the VEGF and VEGFR-1 concentration in tumor homogenates. Tertiary University Hospital Clinic. All tumor homogenates contained VEGF and VEGFR-1. A significant correlation existed between the concentration of both VEGF and VEGFR-1 and tumor growth rate but not symptom duration or tumor size. The concentration of VEGF and VEGFR-1 in VS homogenates correlates with tumor growth rate but not with tumor size or symptom duration. We conclude that VEGF and VEGFR-1 appear to be directly involved in the growth pattern of VS.Keywords
This publication has 11 references indexed in Scilit:
- Immunohistochemical Demonstration of Vascular Endothelial Growth Factor in Vestibular Schwannomas Correlates to Tumor Growth RateThe Laryngoscope, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Signal transduction by vascular endothelial growth factor receptorsBiochemical Society Transactions, 2003
- Vascular Endothelial Growth FactorPublished by Springer Nature ,2003
- Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinomaBritish Journal of Cancer, 2002
- Circulating Angiogenesis Regulators in Cancer PatientsThe International Journal of Biological Markers, 2001
- Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinomaEuropean Journal of Surgical Oncology, 2000
- Vestibular Schwannoma Growth: The Continuing ControversyThe Laryngoscope, 2000
- Clinicopathologic Growth Factors in Vestibular Schwannomas: a Morphological and Immunohistochemical Study of 69 TumoursActa Oto-Laryngologica, 2000
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993